Jennifer E. Cook, a Director at BridgeBio Pharma, Inc. (BBIO), divested a significant portion of her holdings in the company on July 13, 2026. The transaction involved the sale of 112,422 shares at a price of $90.00 per share, resulting in proceeds of approximately $10.12 million.
This sale represents a notable liquidity event for the insider. It is important to note that insider selling can occur for a variety of reasons, including personal financial planning, diversification of assets, or to meet tax obligations, and does not necessarily indicate a change in the insider's or company's fundamental outlook.
The sale by Ms. Cook follows a pattern of recent insider selling activity within BridgeBio Pharma. Earlier in July, another Director, Andrea Ellis, sold shares, and Ms. Cook herself engaged in prior sales in June.